Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Trypanosoma cruzi maxicircle heterogeneity in Chagas disease patients from Brazil

(2009) Julio César Carranza et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina

(2009) Sergio Sosa-Estani et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

(2009) Constança Carvalho Britto   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Ergosterol biosynthesis and drug development for Chagas disease

(2009) Julio A Urbina   MEMORIAS DO INSTITUTO OSWALDO CRUZ

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI

(2009) B Zingales et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins Sans Frontières

(2009) Oliver Yun et al.   PLoS Neglected Tropical Diseases

A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

(2008) Shane R. Wilkinson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic profiling of Trypanosoma cruzi directly in infected tissues using nested PCR of polymorphic microsatellites

(2007) Helder Magno Silva Valadares et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY